Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial
Robert D Little, Jo McKenzie, Ashish Srinivasan, Patrick Hilley, Robert B Gilmore, Desmond Chee, Manjeet Sandhu, Daniel Saitta, Elizabeth Chow, Lena Thin, Gareth J Walker, Gregory T Moore, Kate Lynch, Jane Andrews, Yoon K An, Robert V Bryant, Susan J Connor, Mayur Garg, Emily K Wright, Georgina Hold, Jonathan P Segal, Alex Boussioutas, Peter De Cruz, Mark G Ward, Miles P Sparrow
BMJ Open Jul 2024, 14 (7) e081787; DOI: 10.1136/bmjopen-2023-081787